- Home
- GNK vs CRMD Comparison
GNK vs CRMD Comparison
Compare GNK & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNK
- CRMD
- Stock Information
- Founded
- GNK 2004
- CRMD 2006
- Country
- GNK United States
- CRMD United States
- Employees
- GNK N/A
- CRMD N/A
- Industry
- GNK Marine Transportation
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- GNK Consumer Discretionary
- CRMD Health Care
- Exchange
- GNK Nasdaq
- CRMD Nasdaq
- Market Cap
- GNK 551.2M
- CRMD 464.7M
- IPO Year
- GNK 2005
- CRMD 2010
- Fundamental
- Price
- GNK $14.57
- CRMD $11.63
- Analyst Decision
- GNK Strong Buy
- CRMD Strong Buy
- Analyst Count
- GNK 5
- CRMD 6
- Target Price
- GNK $22.60
- CRMD $15.00
- AVG Volume (30 Days)
- GNK 618.4K
- CRMD 2.3M
- Earning Date
- GNK 05-07-2025
- CRMD 05-06-2025
- Dividend Yield
- GNK 8.16%
- CRMD N/A
- EPS Growth
- GNK 1259.97
- CRMD N/A
- EPS
- GNK 1.05
- CRMD 0.28
- Revenue
- GNK $376,850,000.00
- CRMD $82,553,827.00
- Revenue This Year
- GNK N/A
- CRMD $207.65
- Revenue Next Year
- GNK $15.66
- CRMD $50.13
- P/E Ratio
- GNK $13.94
- CRMD $41.90
- Revenue Growth
- GNK N/A
- CRMD N/A
- 52 Week Low
- GNK $11.20
- CRMD $3.61
- 52 Week High
- GNK $23.43
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- GNK 68.25
- CRMD 69.76
- Support Level
- GNK $13.39
- CRMD $11.21
- Resistance Level
- GNK $13.80
- CRMD $12.31
- Average True Range (ATR)
- GNK 0.33
- CRMD 0.67
- MACD
- GNK 0.18
- CRMD 0.32
- Stochastic Oscillator
- GNK 97.12
- CRMD 82.29
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.